Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciSparc Ltd. ( (SPRC) ) just unveiled an update.
On August 26, 2025, SciSparc Ltd. announced that its shareholders approved all proposals presented at a special general meeting. This approval, in line with Israeli Companies Law, supports the company’s strategic initiatives and reflects shareholder confidence in its direction, potentially strengthening its market position.
More about SciSparc Ltd.
SciSparc Ltd. operates in the pharmaceutical industry, focusing on the development of therapies for the treatment of central nervous system disorders. The company is known for its innovative approach in leveraging cannabinoid-based therapies to address various neurological conditions.
Average Trading Volume: 41,041
Technical Sentiment Signal: Sell
Current Market Cap: $2.26M
For a thorough assessment of SPRC stock, go to TipRanks’ Stock Analysis page.